CClinicalTrials.gg
Status unknownNCT02951520Updated Nov 3, 2016

A Novel Single-puncture Triple Nerve Block; Sciatic, Obturator, Femoral Technique (SOFT), as a Sole Anesthesia for Knee Surgeries

A Phase 4 interventional study of new technique for lower limb nerve blocks using a single skin puncture (SOFT block) in Arthroscopic Knee Ligament Reconstruction, sponsored by Healthpoint Hospital. Status unknown at 1 site in United Arab Emirates. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-11-03.

Sponsored by Healthpoint Hospital · Phase 4, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Nov 2016), so the status shown — last known as Recruiting — may be out of date.
Phase
Phase 4
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to describe and to evaluate the effectiveness (success rate) of a supine ultrasound (US) guided single-puncture sciatic, obturator and femoral neve block technique (SOFT block) in knee surgery.

Read the detailed description

Under aseptic technique, all the patients will receive US-guided femoral, obturator and sciatic nerve blocks using a single puncture point. All blocks will be performed by an expert anesthetist. The femoral nerve will be blocked lateral to the femoral artery. The obturator nerve will be blocked after it exits the obturator canal (deep to pectineus muscle). While the sciatic nerve will be blocked deep (posterior) to the inferior border of quadratus femoris muscle. The motor block of the femoral, obturator and sciatic nerves and sensory block of the lateral femoral cutaneous nerve (LFCN) will be assessed before shifting the patient to the operating room.

The performance time, patient discomfort, technique success rate, the associated successful LFCN block and any complication will be recorded by the assistant. All patients were assessed neurologically before discharge and during the physiotherapy visits for 3 weak after surgery.

02

Conditions studied

  • Arthroscopic Knee Ligament Reconstruction

Keywords

  • Patients
03

In context

Lead sponsor

Healthpoint Hospital is the lead sponsor of 6 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Adult patients scheduled for arthroscopic knee ligament reconstruction

Exclusion criteria

Exclusion Criteria:

  • BMI > 30 kg.m-2,
  • ASA physical state >II
  • Allergy to the used local anesthetics
  • Infection at the injection site
  • age \<18y
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    SOFT block

    Fifty patients will form the study group (one group). All the patients will receive supine ultrasound guided (US) sciatic, obturator, femoral nerve block technique using a single skin puncture (SOFT block).

    Procedure: new technique for lower limb nerve blocks using a single skin puncture (SOFT block)

Interventions

  • Procedurenew technique for lower limb nerve blocks using a single skin puncture (SOFT block)

    The patients will be in supine position. The block needle will be inserted at the inguinal crease (medial to the femoral vein) and advanced towards the femoral nerve, then redirected towards the obturator nerve (deep to the pectineus muscle). Lastly, it will be redirected posteriorly towards the sciatic nerve (deep to the quadratus femoris muscle). A ropivacaine-lidocaine-epinephrine mixture will be used to block these nerves. The block success rate (painless surgery), performance time and patient discomfort will be recorded.

06

What researchers measure

Primary outcomes

  1. success rate

    Time frame: within the perioperative period

07

Study locations

1 of 1 sites recruiting
  • Healthpoint Hospital
    Abu Dhabi, 112308, United Arab Emirates
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 3, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02951520
Lead sponsor
Healthpoint Hospital
Responsible party
Ahmad Muhammad Taha (Consultant of anesthesia, Healthpoint Hospital) — Principal investigator
First posted
Nov 1, 2016
Start date
Oct 2016
Primary completion
Apr 2017 (estimated)
Last update
Nov 3, 2016

Study contacts

Ahmad M Taha, MD
Contact
ahmadtaha_1@yahoo.com
00971508297326
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion